Visit the Knudra/NemaMetrix joint booth at the 21st International C. elegans Meeting to learn latest trends and applications in C. elegans research. Also, stop by for a chance to win a daily prize! Answer a few simply questions to win a $50 Amazon® gift card each day. At the show, our R&D scientists will be [...]
NemaMetrix Inc. was selected as the only company representing the state of Oregon by the Science Coalition in its latest Sparking Economic Growth reports released Apr 25, 2017. Featured as American innovation success stories in the reports are companies created as a result of a discovery from [...]
NemaMetrix’s ScreenChip collects live-animal, high-throughput C. elegans elecropharyngeograms (EPGs), which are an indication of overall organism health for drug development. Read the blog post on BioCoder published by O'Reilly Bio.
NemaMetrix is sponsoring the 2017 Bay Area Worm Meeting at Mission Bay Campus of the University of California, San Francisco, at 600 16th Street, San Francisco, CA 94158, in Genentech Hall. We will be showing live demonstrations of our ScreenChip System and discussing our latest research findings. Dr. Yoanne Clovis from NemaMetrix will be [...]
Eugene, OR. — October 10, 2016 Nemametrix Inc., a fast-growing life sciences startup that created the innovative ScreenChip System for drug screening, mutant phenotyping, and toxicological assessment, has entered into a co-marketing partnership with Knudra Transgenics, a genome engineering company specializing in custom built transgenic model organisms for research and drug discovery. Uniquely aligned in their [...]
Now Available! ScreenChip for L1 stage. Test EPGs in the L1 stage with the NemaMetrix ScreenChip 10. This device enables researchers to quantitatively study EPG waveforms and phenotypes at an earlier developmental timepoint than has previously been possible. Specially sized for L1 stage larvae. Contact email@example.com to find out more. Additional Information
Come and visit our team at the Aging, Metabolism, Pathogenesis, Stress, and Small RNAs in C. elegans conference in Madison, Wisconsin! We'll be showing live demos and discussing the results of our most recent research with the ScreenChip system. We look forward to seeing you there!
NemaMetrix will be attending the The Allied Genetics Conference (TAGC) on July 13-17, 2016. For the first time, researchers studying C. elegans, Drosophila, mouse, zebrafish, yeast, ciliates, and PEQ will be holding meetings under the same roof. We’re excited to take part in this one of a kind event! We are proud to be partnering [...]
NemaMetrix is pleased to announce that we will be attending the 2016 European Worm Meeting in Berlin on June 1-3, 2016. Attending a European conference is a unique opportunity for us to hear about the dynamic C. elegans research occurring far from our home in the US. We are particularly excited to be hosted by [...]
Mike Harris working with the NemaMetrix ScreenChip system during a customer workshop. At our inaugural ScreenChip Workshop, one of our very first customers, Dr. Mike Harris, had a burning question. He'd been collaborating for years on a project that focused on the rabies virus surface glycoprotein (RGP), and through careful characterization, he had found a conserved [...]
Recently, NemaMetrix hosted its inaugural ScreenChip workshop in Eugene, OR. A diverse group of researchers gathered together for a three-day workshop to learn about our technology. Food, lodging and transportation were provided for our guests as well as lab instruments and reagents. Additionally, members of the Nemametrix team gave demonstrations and 1-on-1 tutorials on how to use [...]
NemaMetrix had the wonderful opportunity to connect with many people in the worm community at the 2015 Worm Meeting in Los Angeles. From aging to imaging, drug screening to mutant phenotyping, it was great to hear about all the fantastic research being done out there and how our microfluidics could help. Thanks to [...]
Our Co-founder, Dr. Weeks, gave an impassioned scientific talk in Gabon, discussing her work at the University of Oregon that led her to starting NemaMetrix and receiving a Bill & Melinda Gates Foundation grant for global health research. There is a critical need for new anthelmintic drugs for humans and animals, largely because of increasing [...]
January 28, 2014 – NemaMetrix announces being awarded $188,000 Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Health. The funds will be used to support fundamental proof of concept research, with an eye towards near-term commercialization, of a microfluidic screening devices for health-span extending drugs. Americans aged 85 or older [...]
NemaMetrix announces being awarded $249,000 in GAP funding from Oregon Nanoscience and Microtechnologies Institute (ONAMI) to fund “proof-of-concept” work and to fuel development towards commercialization.